Activation of immune response plays an important role in the development of retinal diseases. One of the main populations of immune cells contributing to the retinal homeostasis are microglia, which represent a population of residential macrophages. However, under pathological conditions, microglia become activated and rather support a harmful inflammatory reaction and retinal angiogenesis. Therefore, targeting these cells could provide protection against retinal neuroinflammation and neovascularization. In the recent study, we analyzed effects of silver nanoparticles (AgNPs) on microglia in vitro and in vivo. We showed that the AgNPs interact in vitro with stimulated mouse CD45/CD11b positive cells (microglia/macrophages), decrease their secretion of nitric oxide and vascular endothelial growth factor, and regulate the expression of genes for Iba-1 and interleukin-1β (IL-1β). In our in vivo experimental mouse model, the intravitreal application of a mixture of proinflammatory cytokines tumor necrosis factor-α, IL-1β and interferon-γ induced local inflammation and increased local expression of genes for inducible nitric oxide synthase, IL-α, IL-1β and galectin-3 in the retina. This stimulation of local inflammatory reaction was significantly inhibited by intravitreal administration of AgNPs. The application of AgNPs also decreased the presence of CD11b/Galectin-3 positive cells in neuroinflammatory retina, but did not influence viability of cells and expression of gene for rhodopsin in the retinal tissue. These data indicate that AgNPs regulate reactivity of activated microglia in the diseased retina and thus could provide a beneficial effect for the treatment of several retinal diseases.

Department of Cell Biology Faculty of Science Charles University 128 43 Prague 2 Czech Republic

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital 121 08 Prague 2 Czech Republic

Department of Toxicology and Molecular Epidemiology Institute of Experimental Medicine of the Czech Academy of Sciences 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Madeira, M.H., R. Boia, P.F. Santos, A.F. Ambrósio, and A.R. Santiago. 2015. Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators of inflammation 2015: 673090. https://doi.org/10.1155/2015/673090 . PubMed DOI PMC

Rashid, K., I. Akhtar-Schaefer, and T. Langmann. 2019. Microglia in retinal degeneration. Frontiers in Immunology 10: 1975. https://doi.org/10.3389/fimmu.2019.01975 . PubMed DOI PMC

Choi, S., L. Guo, and M.F. Cordeiro. 2021. Retinal and brain microglia in multiple sclerosis and neurodegeneration. Cells 10 (6): 1507. https://doi.org/10.3390/cells10061507 . PubMed DOI PMC

Altmann, C., and M.H.H. Schmidt. 2018. The role of microglia in diabetic retinopathy: Inflammation, microvasculature defects and neurodegeneration. International Journal of Molecular Sciences 19 (1): 110. https://doi.org/10.3390/ijms19010110 . PubMed DOI PMC

Kinuthia, U.M., A. Wolf, and T. Langmann. 2020. Microglia and inflammatory responses in diabetic retinopathy. Frontiers in Immunology 11: 564077. https://doi.org/10.3389/fimmu.2020.564077 . PubMed DOI PMC

Noailles, A., V. Maneu, L. Campello, V. Gómez-Vicente, P. Lax, and N. Cuenca. 2016. Persistent inflammatory state after photoreceptor loss in an animal model of retinal degeneration. Scientific Reports 6: 33356. https://doi.org/10.1038/srep33356 . PubMed DOI PMC

Wooff, Y., S.M. Man, R. Aggio-Bruce, R. Natoli, and N. Fernando. 2019. IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative Diseases. Frontiers in Immunology 10: 1618. https://doi.org/10.3389/fimmu.2019.01618 . PubMed DOI PMC

Liu, Y., C. Zhao, J. Meng, N. Li, Z. Xu, X. Liu, and S. Hou. 2022. Galectin-3 regulates microglial activation and promotes inflammation through TLR4/MyD88/NF-kB in experimental autoimmune uveitis. Clinical Immunology (Orlando, Fla.) 236: 108939. https://doi.org/10.1016/j.clim.2022.108939 . PubMed DOI

Bauer, P.M., M.C. Zalis, H. Abdshill, T. Deierborg, F. Johansson, and U. Englund-Johansson. 2016. Inflamed in vitro retina: Cytotoxic neuroinflammation and galectin-3 expression. PLoS ONE 11 (9): e0161723. https://doi.org/10.1371/journal.pone.0161723 . PubMed DOI PMC

Puigdellívol, M., D.H. Allendorf, and G.C. Brown. 2020. Sialylation and galectin-3 in microglia-mediated neuroinflammation and neurodegeneration. Frontiers in Cellular Neuroscience 14: 162. https://doi.org/10.3389/fncel.2020.00162 . PubMed DOI PMC

Mendonça, H.R., J.N.A. Carvalho, C.A. Abreu, Mariano de Souza, D. Aguiar Dos Santos, J.R. Carvalho, S.A. Marques, K. da Costa Calaza, and A.M.B. Martinez. 2018. Lack of galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice. Brain Research 1700: 126–137. https://doi.org/10.1016/j.brainres.2018.07.018 . PubMed DOI

Lalancette-Hébert, M., V. Swarup, J.M. Beaulieu, I. Bohacek, E. Abdelhamid, Y.C. Weng, S. Sato, and J. Kriz. 2012. Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 32 (30): 10383–10395. https://doi.org/10.1523/JNEUROSCI.1498-12.2012 . PubMed DOI

Klębowski, B., J. Depciuch, M. Parlińska-Wojtan, and J. Baran. 2018. Applications of noble metal-based nanoparticles in medicine. International Journal of Molecular Sciences 19 (12): 4031. https://doi.org/10.3390/ijms19124031 . PubMed DOI PMC

Yang, C., J. Yang, A. Lu, J. Gong, Y. Yang, X. Lin, M. Li, and H. Xu. 2022. Nanoparticles in ocular applications and their potential toxicity. Frontiers in Molecular Biosciences 9: 931759. https://doi.org/10.3389/fmolb.2022.931759 . PubMed DOI PMC

Jo, D.H., J.H. Kim, Y.S. Yu, T.G. Lee, and J.H. Kim. 2012. Antiangiogenic effect of silicate nanoparticle on retinal neovascularization induced by vascular endothelial growth factor. Nanomedicine : Nanotechnology, Biology, and Medicine 8 (5): 784–791. https://doi.org/10.1016/j.nano.2011.09.003 . PubMed DOI

Jo, D.H., J.H. Kim, J.G. Son, N.W. Song, Y.I. Kim, Y.S. Yu, T.G. Lee, and J.H. Kim. 2014. Anti-angiogenic effect of bare titanium dioxide nanoparticles on pathologic neovascularization without unbearable toxicity. Nanomedicine : Nanotechnology, Biology, and Medicine 10 (5): 1109–1117. https://doi.org/10.1016/j.nano.2014.02.007 . PubMed DOI

Song, H.B., J.S. Wi, D.H. Jo, J.H. Kim, S.W. Lee, T.G. Lee, and J.H. Kim. 2017. Intraocular application of gold nanodisks optically tuned for optical coherence tomography: Inhibitory effect on retinal neovascularization without unbearable toxicity. Nanomedicine : Nanotechnology, Biology, and Medicine 13 (6): 1901–1911. https://doi.org/10.1016/j.nano.2017.03.016 . PubMed DOI

Fiorani, L., M. Passacantando, S. Santucci, S. Di Marco, S. Bisti, and R. Maccarone. 2015. Cerium oxide nanoparticles reduce microglial activation and neurodegenerative events in light damaged retina. PLoS ONE 10 (10): e0140387. https://doi.org/10.1371/journal.pone.0140387 . PubMed DOI PMC

De Matteis, V., and L. Rizzello. 2020. Noble metals and soft bio-inspired nanoparticles in retinal diseases treatment: A Perspective. Cells 9 (3): 679. https://doi.org/10.3390/cells9030679 . PubMed DOI PMC

Zhang, X.F., Z.G. Liu, W. Shen, and S. Gurunathan. 2016. Silver nanoparticles: Synthesis, characterization, properties, applications, and therapeutic approaches. International Journal of Molecular Sciences 17 (9): 1534. https://doi.org/10.3390/ijms17091534 . PubMed DOI PMC

Brzicova, T., E. Javorkova, K. Vrbova, A. Zajicova, V. Holan, D. Pinkas, V. Philimonenko, J. Sikorova, J. Klema, J. Topinka, and P. Rossner Jr. 2019. Molecular responses in THP-1 macrophage-like cells exposed to diverse nanoparticles. Nanomaterials (Basel, Switzerland) 9 (5): 687. https://doi.org/10.3390/nano9050687 . PubMed DOI

Hermankova, B., J. Kossl, P. Bohacova, E. Javorkova, M. Hajkova, M. Krulova, A. Zajicova, and V. Holan. 2019. The immunomodulatory potential of mesenchymal stem cells in a retinal inflammatory environment. Stem Cell Reviews and Reports 15: 880–891. https://doi.org/10.1007/s12015-019-09908-0 . PubMed DOI

Lin, J., P. Chen, Z. Tan, Y. Sun, W.K. Tam, D. Ao, W. Shen, V.Y. Leung, K.M.C. Cheung, and M.K.T. To. 2023. Application of silver nanoparticles for improving motor recovery after spinal cord injury via reduction of pro-inflammatory M1 macrophages. Heliyon 9 (5): e15689. https://doi.org/10.1016/j.heliyon.2023.e15689 . PubMed DOI PMC

Söderstjerna, E., P. Bauer, T. Cedervall, H. Abdshill, F. Johansson, and U.E. Johansson. 2014. Silver and gold nanoparticles exposure to in vitro cultured retina–studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity. PLoS ONE 9 (8): e105359. https://doi.org/10.1371/journal.pone.0105359 . PubMed DOI PMC

Hinze, A., and A. Stolzing. 2011. Differentiation of mouse bone marrow derived stem cells toward microglia-like cells. BMC Cell Biology 12: 35. https://doi.org/10.1186/1471-2121-12-35 . PubMed DOI PMC

Chauhan, M.Z., P.A. Rather, S.M. Samarah, A.M. Elhusseiny, and A.B. Sallam. 2022. Current and novel therapeutic approaches for treatment of diabetic macular edema. Cells 11 (12): 1950. https://doi.org/10.3390/cells11121950 . PubMed DOI PMC

Wesley, U.V., R. Vemuganti, E.R. Ayvaci, and R.J. Dempsey. 2013. Galectin-3 enhances angiogenic and migratory potential of microglial cells via modulation of integrin linked kinase signaling. Brain Research 1496: 1–9. https://doi.org/10.1016/j.brainres.2012.12.008 . PubMed DOI

Lappas, C.M. 2015. The immunomodulatory effects of titanium dioxide and silver nanoparticles. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 85: 78–83. https://doi.org/10.1016/j.fct.2015.05.015 . PubMed DOI

Vuković, B., Ž Cvetić, K. Bendelja, R. Barbir, M. Milić, B. Dobrošević, V. Šerić, and I. Vinković Vrček. 2021. In vitro study on the immunomodulatory effects of differently functionalized silver nanoparticles on human peripheral blood mononuclear cells. Journal of Biological Inorganic Chemistry : JBIC : A Publication of the Society of Biological Inorganic Chemistry 26 (7): 817–831. https://doi.org/10.1007/s00775-021-01898-0 . PubMed DOI

Mohammapdour, R., and H. Ghandehari. 2022. Mechanisms of immune response to inorganic nanoparticles and their degradation products. Advanced Drug Delivery Reviews 180: 114022. https://doi.org/10.1016/j.addr.2021.114022 . PubMed DOI

Radwan, I.M., A. Gitipour, P.M. Potter, D.D. Dionysiou, and S.R. Al-Abed. 2019. Dissolution of Silver Nanoparticles in Colloidal Consumer Products: Effects of Particle Size and Capping Agent. Journal of Nanoparticle Research : An Interdisciplinary Forum for Nanoscale Science and Technology 21 (7): 1–155. https://doi.org/10.1007/s11051-019-4597-z . PubMed DOI

Fahmy, H.M., A.M. Mosleh, A.A. Elghany, E. Shams-Eldin, E.S. Abu Serea, S.A. Ali, and A.E. Shalan. 2019. Coated silver nanoparticles: Synthesis, cytotoxicity, and optical properties. RSC Advances 9 (35): 20118–20136. https://doi.org/10.1039/c9ra02907a . PubMed DOI PMC

Velgosova, O., L. Mačák, E. Múdra, M. Vojtko, and M. Lisnichuk. 2023. Preparation, Structure, and Properties of PVA-AgNPs Nanocomposites. Polymers 15 (2): 379. https://doi.org/10.3390/polym15020379 . PubMed DOI PMC

Matras, E., A. Gorczyca, S.W. Przemieniecki, and M. Oćwieja. 2022. Surface properties-dependent antifungal activity of silver nanoparticles. Scientific Reports 12 (1): 18046. https://doi.org/10.1038/s41598-022-22659-2 . PubMed DOI PMC